Biotech/Pharmaceuticals
- Article Tools
- Email this Article
- Print this Article
- Rss Feed
- Related Articles
- FDA Approves Brain Stent
- Pfizer Files Sutent Application
- Back to Drawing Board for Gilead
- Del.icio.us
- Digg
- StumbleUpon
Procter & Gamble PG said the Food and Drug Administration approved its Actonel with Calcium for osteoporosis. P&G said Actonel with Calcium is the first prescription osteoporosis therapy to include calcium. The drug is marketed by the Alliance for Better Bone Health, a collaboration between Procter & Gamble Pharmaceuticals and Sanofi-Aventis SNY unit Aventis Pharmaceuticals. Actonel with Calcium is a prescription therapy indicated for the prevention and treatment of postmenopausal osteoporosis. Actonel with Calcium includes four weeks of therapy. Each week contains seven tablets (one 35 mg once-a-week Actonel tablet and six tablets that each provide 500 mg calcium). This new treatment option comes in light of the recent Surgeon General's Report on Bone Health and Osteoporosis which emphasizes the need for osteoporosis regimens to be simplified and organized, the company said. On Monday, Procter & Gamble rose 85 cents to $54.40, and Sanofi fell 62 cents to $43.43.
Boston Scientific gets a humanitarian device exemption for the device.
The cancer treatment fights gastrointestinal stromal tumors and renal cell carcinoma.
A combination of two HIV drugs failed bioequivalence tests, the company says.
Yahoo! is among the most searched stocks on TheStreet.com. Here's what Cramer had to say about the stock recently.
Catch up on his thinking on the hottest topics of the past week.
Investors will have to deal with a Fed meeting and another flood of earnings and economic data.
Ensco International and Echelon have the potential to move higher in coming days.
See who made what calls.
The addition of video is helping telecom companies compete against cable and satellite companies.
The June West Texas Intermediate contract reflects selling pressure ahead of Tuesday's expiration. But stocks in the sector are generally trading higher.
See who made what calls.
Keep on top of the market and the critical information you need to make more profitable investing decisions.
Sponsored by:
RSS
